|
|||||
|
|
IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells |
|
| Authors: | Yanqiang Chen Jianzhen Liu Pei Lv Jiangyan Gao Mingzheng Wang |
| Institution: | 1. Department of Neurology, Hebei Chest Hospital, Shijiazhuang, Hebei, China;2. Department of Urology, Hebei Chest Hospital, Shijiazhuang, Hebei, China;3. Department of Nephrology, Hebei Chest Hospital, Shijiazhuang, Hebei, China;4. Cardiovascular Department, Hebei Chest Hospital, Shijiazhuang, Hebei, China;5. Department of Thoracic Surgery, Hebei Chest Hospital, Shijiazhuang, Hebei, China |
| Abstract: | |
| Keywords: | Dox ERK1/2 IL-6 renal cancer STAT3 |